Similar Items: Clinical outcomes and safety profile of emicizumab and other treatment options for the management of children and adults with severe haemophilia A in the UAE: A retrospective study at two tertiary hospitals
- Severe haemophilia A with haemarthrosis improved on emicizumab: A case report
- Perceived experiences of people with severe haemophilia A switching from factor VIII prophylaxis to emicizumab
- Clinical profile and outcome of children with haemophilia A: The Royal Hospital, Oman’s experience
- Outcomes, challenges and prospects of emicizumab prophylaxis in Sub-Saharan Africa – Insights from the Tanzanian experience
- Listeriosis – a retrospective study of 5 years on risk factors and clinical outcomes at a tertiary care hospital in Islamabad, Pakistan
- Acquired haemophilia A: Balancing on the edge of haemostasis – Case series